Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation

ClinicalTrials.gov ID: NCT00402363

Public ClinicalTrials.gov record NCT00402363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 1:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Efficacy and Safety of Lovaza for the Prevention of Recurrent, Symptomatic Atrial Fibrillation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate efficacy and safety of Omacor (omega-3-acid ethyl esters) in patients with recurrent, symptomatic atrial fibrillation.

Study identification

NCT ID
NCT00402363
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
663 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
Jan 2010 (Actual)
Completion
Jan 2010 (Actual)
Last update posted
Jan 30, 2017

2006 – 2010

United States locations

U.S. sites
178
U.S. states
40
U.S. cities
152
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35215 —
GSK Investigational Site Huntsville Alabama 35801 —
GSK Investigational Site Anchorage Alaska 99508 —
GSK Investigational Site Cottonwood Arizona 86326 —
GSK Investigational Site Mesa Arizona 85206 —
GSK Investigational Site Phoenix Arizona 85006 —
GSK Investigational Site Phoenix Arizona 85014 —
GSK Investigational Site Phoenix Arizona 85032 —
GSK Investigational Site Tucson Arizona 85724 —
GSK Investigational Site Fort Smith Arkansas 72901 —
GSK Investigational Site Hot Springs Arkansas 71913 —
GSK Investigational Site Alamada California 94501 —
GSK Investigational Site Bakersfield California 93301 —
GSK Investigational Site Bakersfield California 93308 —
GSK Investigational Site Beverly Hills California 90210 —
GSK Investigational Site Carmichael California 95608 —
GSK Investigational Site Fair Oaks California 95628 —
GSK Investigational Site Fountain Valley California 92708 —
GSK Investigational Site Loma Linda California 92354 —
GSK Investigational Site Los Angeles California 90033 —
GSK Investigational Site Los Angeles California 90048 —
GSK Investigational Site Los Angeles California 90073 —
GSK Investigational Site Los Angeles California 90211 —
GSK Investigational Site Merced California 95348 —
GSK Investigational Site Palm Springs California 92262 —
GSK Investigational Site Poway California 92064 —
GSK Investigational Site Redondo Beach California 90277 —
GSK Investigational Site Sacramento California 95819 —
GSK Investigational Site San Diego California 92120 —
GSK Investigational Site San Diego California 92123 —
GSK Investigational Site San Diego California 92161 —
GSK Investigational Site Vista California 92081 —
GSK Investigational Site Walnut Creek California 94598 —
GSK Investigational Site Aurora Colorado 80012 —
GSK Investigational Site Colorado Springs Colorado 80907 —
GSK Investigational Site Littleton Colorado 80120 —
GSK Investigational Site Bridgeport Connecticut 06606 —
GSK Investigational Site Farmington Connecticut 06030 —
GSK Investigational Site Guilford Connecticut 06437 —
GSK Investigational Site Washington D.C. District of Columbia 20010 —
GSK Investigational Site Washington D.C. District of Columbia 20017 —
GSK Investigational Site Aventura Florida 33180 —
GSK Investigational Site Bay Pines Florida 33744 —
GSK Investigational Site Daytona Beach Florida 32114 —
GSK Investigational Site Delray Beach Florida 33484 —
GSK Investigational Site Fort Meyers Florida 33919 —
GSK Investigational Site Gainesville Florida 32605 —
GSK Investigational Site Hudson Florida 34667 —
GSK Investigational Site Jacksonville Florida 32207 —
GSK Investigational Site Jacksonville Florida 32216 —
GSK Investigational Site Jupiter Florida 33458 —
GSK Investigational Site Kissimmee Florida 34741 —
GSK Investigational Site Largo Florida 33773 —
GSK Investigational Site Melbourne Florida 32901 —
GSK Investigational Site Miami Florida 33136 —
GSK Investigational Site Miami Florida 33137 —
GSK Investigational Site Miami Florida 33176 —
GSK Investigational Site Ocala Florida 34471 —
GSK Investigational Site Orlando Florida 32803 —
GSK Investigational Site Ormond Beach Florida 32174 —
GSK Investigational Site Pensacola Florida 32514 —
GSK Investigational Site Pinellas Park Florida 33781 —
GSK Investigational Site Tampa Florida 33607 —
GSK Investigational Site Atlanta Georgia 30322 —
GSK Investigational Site Atlanta Georgia 30328 —
GSK Investigational Site Atlanta Georgia 30342 —
GSK Investigational Site Decatur Georgia 30030 —
GSK Investigational Site Tucker Georgia 30084 —
GSK Investigational Site Bannockburn Illinois 60015 —
GSK Investigational Site Gurnee Illinois 60031 —
GSK Investigational Site Normal Illinois 61761 —
GSK Investigational Site Peoria Illinois 61603 —
GSK Investigational Site Elkhart Indiana 46514 —
GSK Investigational Site Indianapolis Indiana 46260 —
GSK Investigational Site La Porte Indiana 46350 —
GSK Investigational Site South Bend Indiana 46601 —
GSK Investigational Site Kansas City Kansas 66102 —
GSK Investigational Site Louisville Kentucky 40205 —
GSK Investigational Site Mount Sterling Kentucky 40353 —
GSK Investigational Site Covington Louisiana 70433 —
GSK Investigational Site Lacombe Louisiana 70445 —
GSK Investigational Site Auburn Maine 04210 —
GSK Investigational Site Biddeford Maine 04005 —
GSK Investigational Site Portland Maine 04106 —
GSK Investigational Site Scarborough Maine 04074 —
GSK Investigational Site Annapolis Maryland 20401 —
GSK Investigational Site Ayer Massachusetts 01432 —
GSK Investigational Site Brookline Massachusetts 02446 —
GSK Investigational Site Worcester Massachusetts 01655 —
GSK Investigational Site Alpena Michigan 49707 —
GSK Investigational Site Cadillac Michigan 49601 —
GSK Investigational Site Detroit Michigan 48201 —
GSK Investigational Site Kalamazoo Michigan 49048 —
GSK Investigational Site Lansing Michigan 48910 —
GSK Investigational Site Mineappolis Minnesota 55417 —
GSK Investigational Site Rochester Hills Minnesota 48307 —
GSK Investigational Site Saint Paul Minnesota 55102 —
GSK Investigational Site Gulfport Mississippi 39503 —
GSK Investigational Site Billings Montana 59101 —
GSK Investigational Site Kalispell Montana 59901 —
GSK Investigational Site Missoula Montana 59802 —
GSK Investigational Site Morristown New Jersey 07962 —
GSK Investigational Site Summit New Jersey 07901 —
GSK Investigational Site Wayne New Jersey 07470 —
GSK Investigational Site Babylon New York 11702 —
GSK Investigational Site Buffalo New York 14209 —
GSK Investigational Site Buffalo New York 14215 —
GSK Investigational Site Mineola New York 11501 —
GSK Investigational Site New York New York 10021 —
GSK Investigational Site New York New York 10025 —
GSK Investigational Site New York New York 10029 —
GSK Investigational Site New York New York 10032 —
GSK Investigational Site Troy New York 12180 —
GSK Investigational Site West Islip New York 11794 —
GSK Investigational Site Charlotte North Carolina 28080 —
GSK Investigational Site Charlotte North Carolina 28203 —
GSK Investigational Site Hickory North Carolina 28601 —
GSK Investigational Site Statesville North Carolina 28625 —
GSK Investigational Site Grand Forks North Dakota 58201 —
GSK Investigational Site Akron Ohio 44304 —
GSK Investigational Site Bryan Ohio 43506 —
GSK Investigational Site Cincinnati Ohio 45219 —
GSK Investigational Site Cleveland Ohio 44106 —
GSK Investigational Site Fairview Park Ohio 44126 —
GSK Investigational Site Oklahoma City Oklahoma 73103 —
GSK Investigational Site Oklahoma City Oklahoma 73104 —
GSK Investigational Site Oklahoma City Oklahoma 73109 —
GSK Investigational Site Corvalis Oregon 97330 —
GSK Investigational Site Hillsboro Oregon 97123-4117 —
GSK Investigational Site Portland Oregon 97220 —
GSK Investigational Site Portland Oregon 97223 —
GSK Investigational Site Beaver Pennsylvania 15009 —
GSK Investigational Site Greensburg Pennsylvania 15601 —
GSK Investigational Site Hershey Pennsylvania 17033 —
GSK Investigational Site Langhorne Pennsylvania 19047 —
GSK Investigational Site Philadelphia Pennsylvania 19102 —
GSK Investigational Site Ridley Park Pennsylvania 19078 —
GSK Investigational Site West Chester Pennsylvania 19380 —
GSK Investigational Site Wynnewood Pennsylvania 19096 —
GSK Investigational Site Wyomissing Pennsylvania 19610 —
GSK Investigational Site Cranston Rhode Island 02920 —
GSK Investigational Site Pawtucket Rhode Island 02860 —
GSK Investigational Site Westerly Rhode Island 02891 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Spartanburg South Carolina 29302 —
GSK Investigational Site Sioux Falls South Dakota 57105 —
GSK Investigational Site Jackson Tennessee 38301 —
GSK Investigational Site Memphis Tennessee 38120 —
GSK Investigational Site Austin Texas 78705 —
GSK Investigational Site Beaumont Texas 77702 —
GSK Investigational Site Corpus Christi Texas 78404 —
GSK Investigational Site Dallas Texas 75230 —
GSK Investigational Site Dallas Texas 75231 —
GSK Investigational Site Houston Texas 77074 —
GSK Investigational Site Houston Texas 77090 —
GSK Investigational Site Humble Texas 77338 —
GSK Investigational Site Lubbock Texas 79410 —
GSK Investigational Site McKinney Texas 75069 —
GSK Investigational Site Odessa Texas 79761 —
GSK Investigational Site Odessa Texas 79764 —
GSK Investigational Site Orange Texas 77630 —
GSK Investigational Site Tyler Texas 75701 —
GSK Investigational Site Waco Texas 76712 —
GSK Investigational Site Salt Lake City Utah 84124 —
GSK Investigational Site Arlington Virginia 22204 —
GSK Investigational Site Chesapeake Virginia 23510 —
GSK Investigational Site Galax Virginia 24333 —
GSK Investigational Site Richlands Virginia 24641 —
GSK Investigational Site Richmond Virginia 23249 —
GSK Investigational Site Richmond Virginia 23294 —
GSK Investigational Site Springfield Virginia 22151 —
GSK Investigational Site Burien Washington 98166 —
GSK Investigational Site Huntington West Virginia 25701 —
GSK Investigational Site Beloit Wisconsin 53511 —
GSK Investigational Site Madison Wisconsin 53792 —
GSK Investigational Site Marshfield Wisconsin 54449 —
GSK Investigational Site Milwaukee Wisconsin 53215 —
GSK Investigational Site Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00402363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2017 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00402363 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →